OXI1 and DAD Regulate Light-Induced Cell Death Antagonistically Through Jasmonate and Salicylate Levels1
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Methods for Using Small Non-Coding Rnas to Improve Recombinant Protein Expression in Mammalian Cells
G C A T T A C G G C A T genes Review Methods for Using Small Non-Coding RNAs to Improve Recombinant Protein Expression in Mammalian Cells Sarah Inwood 1,2 ID , Michael J. Betenbaugh 2 and Joseph Shiloach 1,* 1 Biotechnology Core Laboratory, NIDDK, NIH, Bethesda, MD 20892, USA; [email protected] 2 Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD 21218, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-301-496-9719 Received: 17 November 2017; Accepted: 3 January 2018; Published: 9 January 2018 Abstract: The ability to produce recombinant proteins by utilizing different “cell factories” revolutionized the biotherapeutic and pharmaceutical industry. Chinese hamster ovary (CHO) cells are the dominant industrial producer, especially for antibodies. Human embryonic kidney cells (HEK), while not being as widely used as CHO cells, are used where CHO cells are unable to meet the needs for expression, such as growth factors. Therefore, improving recombinant protein expression from mammalian cells is a priority, and continuing effort is being devoted to this topic. Non-coding RNAs are RNA segments that are not translated into a protein and often have a regulatory role. Since their discovery, major progress has been made towards understanding their functions. Non-coding RNA has been investigated extensively in relation to disease, especially cancer, and recently they have also been used as a method for engineering cells to improve their protein expression capability. In this review, we provide information about methods used to identify non-coding RNAs with the potential of improving recombinant protein expression in mammalian cell lines. -
A 40-Cm Region on Chromosome 14 Plays a Critical Role in the Development of Virus Persistence, Demyelination, Brain Pathology An
A 40-cM Region on Chromosome 14 Plays a Critical Role in the Development of Virus Persistence, Demyelination, Brain Pathology and Neurologic Deficits in a Murine Viral Model of Multiple Sclerosis Shunya Nakane, Laurie Zoecklein, Jeffrey Gamez, Louisa Papke, Kevin Pavelko, Jean- François Bureau, Michel Brahic, Larry Pease, Moses Rodriguez To cite this version: Shunya Nakane, Laurie Zoecklein, Jeffrey Gamez, Louisa Papke, Kevin Pavelko, et al.. A 40-cM Region on Chromosome 14 Plays a Critical Role in the Development of Virus Persistence, Demyelination, Brain Pathology and Neurologic Deficits in a Murine Viral Model of Multiple Sclerosis. Brain Pathology, Wiley, 2003, 13 (4), pp.519-533. 10.1111/j.1750-3639.2003.tb00482.x. hal-03223233 HAL Id: hal-03223233 https://hal.archives-ouvertes.fr/hal-03223233 Submitted on 10 May 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. RESEARCH ARTICLE A 40-cM Region on Chromosome 14 Plays a Critical Role in the Development of Virus Persistence, Demyelination, Brain Pathology and Neurologic Deficits in a Murine Viral Model of Multiple Sclerosis Shunya Nakane1; Laurie J. Zoecklein1; Jeffrey D. Introduction Gamez1; Louisa M. Papke1; Kevin D. -
The Highly Conserved Defender Against the Death 1 (DAD1) Gene
FEBS Letters 363 (1995) 304-306 FEBS 15393 The highly conserved defender against the death 1 (DAD 1) gene maps to human chromosome 14qll-q12 and mouse chromosome 14 and has plant and nematode homologs Suneel S. Apte"'*, Marie-Genevieve Mattei b, Michael F. Seldin c, Bjorn R. Olsen a aDepartment of Cell Biology, Harvard Medical School, 25 Shattuck St., Boston, MA 02115, USA bHopital d'Enfants, INSERM U 406, Groupe Hospitalier de la Timone, 13385 Marseille Cedex 5, France CDepartments of Medicine and Microbiology, Duke University School of Medicine, Box 3380, Durham, NC 27710, USA Received 8 March 1995 demonstrated the remarkable degree of conservation of this Abstract We have cloned the cDNA encoding the mouse DAD1 protein in these 3 species [5]. It is identical in humans and (defender against apoptotic cell death) protein. While showing an hamster and varies only slightly in Xenopus. No homologies expected high homology with the previously cloned human and with previously isolated genes have been reported, and neither Xenopus DADl-encoding cDNAs, this sequence has striking ho- mology to partial eDNA sequences reported from Oo sativa (rice) the precise intracellular localization nor the protein-protein and C. elegans (nematode), suggesting the existence of plant and interactions of DAD1 are currently known [5]. invertebrate homologs of this highly conserved gene. The human We report the cloning of the mouse Dadl eDNA. As ex- and mouse DAD1 genes map to chromosome 14qll-q12 and pected, this is similar to the previously cloned human and chromosome 14, respectively. This mapping data supports and hamster cDNAs. -
Novel Targets of Apparently Idiopathic Male Infertility
International Journal of Molecular Sciences Review Molecular Biology of Spermatogenesis: Novel Targets of Apparently Idiopathic Male Infertility Rossella Cannarella * , Rosita A. Condorelli , Laura M. Mongioì, Sandro La Vignera * and Aldo E. Calogero Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy; [email protected] (R.A.C.); [email protected] (L.M.M.); [email protected] (A.E.C.) * Correspondence: [email protected] (R.C.); [email protected] (S.L.V.) Received: 8 February 2020; Accepted: 2 March 2020; Published: 3 March 2020 Abstract: Male infertility affects half of infertile couples and, currently, a relevant percentage of cases of male infertility is considered as idiopathic. Although the male contribution to human fertilization has traditionally been restricted to sperm DNA, current evidence suggest that a relevant number of sperm transcripts and proteins are involved in acrosome reactions, sperm-oocyte fusion and, once released into the oocyte, embryo growth and development. The aim of this review is to provide updated and comprehensive insight into the molecular biology of spermatogenesis, including evidence on spermatogenetic failure and underlining the role of the sperm-carried molecular factors involved in oocyte fertilization and embryo growth. This represents the first step in the identification of new possible diagnostic and, possibly, therapeutic markers in the field of apparently idiopathic male infertility. Keywords: spermatogenetic failure; embryo growth; male infertility; spermatogenesis; recurrent pregnancy loss; sperm proteome; DNA fragmentation; sperm transcriptome 1. Introduction Infertility is a widespread condition in industrialized countries, affecting up to 15% of couples of childbearing age [1]. It is defined as the inability to achieve conception after 1–2 years of unprotected sexual intercourse [2]. -
14Q11.2 Deletions FTNW
14q11.2 deletions rarechromo.org 14q11.2 deletions A chromosome 14 deletion means that part of one of the body’s chromosomes (chromosome 14) has been lost or deleted. If the material that has been deleted contains important genes, learning disability, developmental delay and health problems may occur. How serious these problems are depends on how much of the chromosome has been deleted and where precisely the deletion is. Genes and chromosomes Our bodies are made up of billions of cells. Most of these cells contain a complete set of thousands of genes that act as instructions, controlling growth, development and how our bodies work. Inside human cells there is a nucleus where the genes are carried on microscopically small, thread-like structures called chromosomes which are made up of DNA. Chromosomes come in pairs of different sizes and are numbered 1-22 from largest to smallest, roughly according to their size. In addition to these so-called autosomal chromosomes there are the sex chromosomes, X and Y. So a human cell has 46 p arm p arm chromosomes: 23 inherited from the mother and 23 p arm p arm inherited from the father, making two sets of 23 chromosomes. A girl will have two X chromosomes (XX) while a boy will have one X and one Y chromosome (XY). Each chromosome has a short (p) arm (at the top in the diagram on this page) and a long (q) arm (at the bottom of the diagram). In a 14q deletion, material has been lost from the long arm of one chromosome 14. -
14Q11.2 Deletions FTNP
Support and Information Rare Chromosome Disorder Support Group, G1, The Stables, Station Road West, Oxted, Surrey RH8 9EE, United Kingdom Tel/Fax: +44(0)1883 723356 [email protected] III www.rarechromo.org Unique is a charity without government funding, existing entirely on donations 14q11.2 deletions and grants. If you are able to support our work in any way, however small, please make a donation via our website at www.rarechromo.org/html/MakingADonation.asp Please help us to help you! This information guide is not a substitute for personal medical advice. Families should consult a medically qualified clinician in all matters relating to genetic diagnosis, management and health. Information on genetic changes is a very fast-moving field and while the information in this guide is believed to be the best available at the time of publication, some facts may later change. Unique does its best to keep abreast of changing information and to review its published guides as needed. It was compiled by Unique and reviewed by Jana Drábová, Division of Medical Cytogenetics, Department of Biology and Medical Genetics, Charles University 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic. 2016 Version 1 (PM) Copyright © Unique 2016 20 Rare Chromosome Disorder Support Group Charity Number 1110661 Registered in England and Wales Company Number 5460413 rarechromo.org 14q11.2 deletions Genes A chromosome 14 deletion means that part of one of the body’s chromosomes (chromosome 14) has been lost or deleted. If the material that has been deleted contains important genes, learning disability, developmental delay and health HNRNPC problems may occur. -
Table S1. 103 Ferroptosis-Related Genes Retrieved from the Genecards
Table S1. 103 ferroptosis-related genes retrieved from the GeneCards. Gene Symbol Description Category GPX4 Glutathione Peroxidase 4 Protein Coding AIFM2 Apoptosis Inducing Factor Mitochondria Associated 2 Protein Coding TP53 Tumor Protein P53 Protein Coding ACSL4 Acyl-CoA Synthetase Long Chain Family Member 4 Protein Coding SLC7A11 Solute Carrier Family 7 Member 11 Protein Coding VDAC2 Voltage Dependent Anion Channel 2 Protein Coding VDAC3 Voltage Dependent Anion Channel 3 Protein Coding ATG5 Autophagy Related 5 Protein Coding ATG7 Autophagy Related 7 Protein Coding NCOA4 Nuclear Receptor Coactivator 4 Protein Coding HMOX1 Heme Oxygenase 1 Protein Coding SLC3A2 Solute Carrier Family 3 Member 2 Protein Coding ALOX15 Arachidonate 15-Lipoxygenase Protein Coding BECN1 Beclin 1 Protein Coding PRKAA1 Protein Kinase AMP-Activated Catalytic Subunit Alpha 1 Protein Coding SAT1 Spermidine/Spermine N1-Acetyltransferase 1 Protein Coding NF2 Neurofibromin 2 Protein Coding YAP1 Yes1 Associated Transcriptional Regulator Protein Coding FTH1 Ferritin Heavy Chain 1 Protein Coding TF Transferrin Protein Coding TFRC Transferrin Receptor Protein Coding FTL Ferritin Light Chain Protein Coding CYBB Cytochrome B-245 Beta Chain Protein Coding GSS Glutathione Synthetase Protein Coding CP Ceruloplasmin Protein Coding PRNP Prion Protein Protein Coding SLC11A2 Solute Carrier Family 11 Member 2 Protein Coding SLC40A1 Solute Carrier Family 40 Member 1 Protein Coding STEAP3 STEAP3 Metalloreductase Protein Coding ACSL1 Acyl-CoA Synthetase Long Chain Family Member 1 Protein -
Copy Number Variation Analysis in Turkish Patients with Congenital Bilateral Absence of Vas Deferens
RESEARCH ARTICLE Acta Medica Alanya 2021;5(2): 181-189 ARAŞTIRMA DOI:10.30565/medalanya.966940 Copy Number Variation Analysis in Turkish Patients with Congenital Bilateral Absence of Vas Deferens Konjenital Bilateral Vas Deferens Yokluğu Olan Türk Hastalarda Genomik Kopya Sayısı Varyasyonları Analizi Durkadin Demir Eksi1*, Elanur Yilmaz², Yigit Akin3, Mustafa Faruk Usta4, Mehmet Murad Basar5, Semra Kahraman⁶, Munire Erman⁷, Ozgul M Alper⁸ 1. Alanya Alaaddin Keykubat University, Faculty of Medicine, Department of Medical Biology, Antalya, Turkey 2. Koç University, Research Center of Translational Medicine İstanbul, Turkey 3. İzmir Katip Çelebi University, Faculty of Medicine, Department of Urology, İzmir, Turkey 4. Akdeniz University, Faculty of Medicine, Department of Urology, Antalya, Turkey 5. Memorial Şişli Hospital, Department of Urology, İstanbul, Turkey 6. Memorial Şişli Hospital, Department of Gynecology and Obstetrics, İstanbul, Turkey 7. Akdeniz University, Faculty of Medicine, Department of Gynecology and Obstetrics, Antalya, Turkey 8. Akdeniz University, Faculty of Medicine, Department of Medical Biology and Genetics, Antalya, Turkey ABSTRACT ÖZ Objective: Congenital Bilateral Absence of the Vas Deferens (CBAVD) is a Amaç: Konjenital Bilateral Vas Deferens Yokluğu (CBAVD), erkeklerde infertiliteye developmental abnormality that causes infertility in males. According to the yol açan gelişimsel bir anomalidir. Literatüre göre CBAVD’li olguların %88’e kadarı en literature, up to 88% of CBAVD cases have at least one pathogenic Cystic Fibrosis az bir Kistik Fibrozis Transmembran Regülatör geni (CFTR) mutasyonuna sahiptir. Transmembrane Conductance Regulator gene (CFTR) mutation. However, based on Ancak, daha önceki verilerimize göre CBAVD’li Türk hastalarda bu oran %15.90’dır. our previous data, this rate was 15.90% in Turkish patients with CBAVD. -
Gene Expression Profiling Induced by Histone Deacetylase Inhibitor, FK228, in Human Esophageal Squamous Cancer Cells
585-592 25/7/07 16:27 Page 585 ONCOLOGY REPORTS 18: 585-592, 2007 585 Gene expression profiling induced by histone deacetylase inhibitor, FK228, in human esophageal squamous cancer cells ISAMU HOSHINO, HISAHIRO MATSUBARA, YASUNORI AKUTSU, TAKANORI NISHIMORI, YASUO YONEYAMA, KENTARO MURAKAMI, AKI KOMATSU, HARUHITO SAKATA, KAZUYUKI MATSUSHITA and TAKENORI OCHIAI Department of Frontier Surgery, Chiba University, Graduate School of Medicine, Chiba, Japan Received March 31, 2007; Accepted May 29, 2007 Abstract. Histone deacetylase inhibitors (HDACIs) are optimal chemotherapy agents for ESCC (3). However, the promising therapeutic agents with the potential for regulating response rates of these combination chemotherapies are not cell cycle, differentiation and apoptosis in cancer cells. satisfactory and the development of new anticancer drugs is HDACI activity is associated with selective transcriptional expected to improve the prognosis of ESCC. Histone regulation and altering gene expression. However, the exact deacetylase inhibitors (HDACIs) are considered to represent mechanisms leading to the antitumor effect of HDACIs are one of the most promising agents for this purpose. not fully understood. FK228, one of the powerful HDACIs, The balance of acetylation by histone acetylases and strongly inhibited cell growth of T.Tn and TE2 cells and deacetylation by histone deacetylase prevents full acetylation, induced apoptosis. Therefore, comprehensive analysis of the thereby creating a default underacetylated state. Acetylated changes in gene expression in human esophageal cancer cell histone tails and other chromosome-associated proteins have lines by the HDACI FK228 was carried out by microarray been identified in nucleosomes and shown to be important in analysis. This analysis was used to clarify the expression regulating gene expression (4,5). -
Evidence for RPGRIP1 Gene As Risk Factor for Primary Open Angle Glaucoma
European Journal of Human Genetics (2011) 19, 445–451 & 2011 Macmillan Publishers Limited All rights reserved 1018-4813/11 www.nature.com/ejhg ARTICLE Evidence for RPGRIP1 gene as risk factor for primary open angle glaucoma Lorena Ferna´ndez-Martı´nez1, Stef Letteboer2, Christian Y Mardin3, Nicole Weisschuh4, Eugen Gramer5, Bernhard HF Weber6, Bernd Rautenstrauss1,8, Paulo A Ferreira7, Friedrich E Kruse3, Andre´ Reis1, Ronald Roepman2 and Francesca Pasutto*,1 Glaucoma is a genetically heterogeneous disorder and is the second cause of blindness worldwide owing to the progressive degeneration of retinal ganglion neurons. Very few genes causing glaucoma were identified to this date. In this study, we screened 10 candidate genes of glaucoma between the D14S261 and D14S121 markers of chromosome 14q11, a critical region previously linked to primary open-angle glaucoma (POAG). Mutation analyses of two large cohorts of patients with POAG, normal tension glaucoma (NTG) and juvenile open-angle glaucoma (JOAG), and control subjects, found only association of non-synonymous heterozygous variants of the retinitis pigmentosa GTPase regulator-interacting protein 1 (RPGRIP1) with POAG, NTG and JOAG. The 20 non-synonymous variants identified in RPGRIP1 were all distinct from variants causing photoreceptor dystrophies and were found throughout all but one domain (RPGR-interacting domain) of RPGRIP1. Among them, 14 missense variants clustered within or around the C2 domains of RPGRIP1. Yeast two-hybrid analyses of a subset of the missense mutations within the C2 domains of RPGRIP1 shows that five of them (p.R598Q, p.A635G, p.T806I, p.A837G and p.I838V) decrease the association of the C2 domains with nephrocystin-4 (NPHPH). -
High-Resolution Genomic Profiling Reveals Gain of Chromosome 14 As
Endocrine-Related Cancer (2009) 16 953–966 High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids Ellinor Andersson1, Christina Swa¨rd 2,Go¨ran Stenman1,Ha˚kan Ahlman 2 and Ola Nilsson1 1Lundberg Laboratory for Cancer Research, Department of Pathology and 2Lundberg Laboratory for Cancer Research, Department of Surgery, Sahlgrenska University Hospital, Gula Stra˚ket 8, SE-413 45 Go¨teborg, Sweden (Correspondence should be addressed to O Nilsson; Email: [email protected]) Abstract Ileal carcinoids are malignant neuroendocrine tumours of the small intestine. The aim of this study was to obtain a high-resolution genomic profile of ileal carcinoids in order to define genetic changes important for tumour initiation, progression and survival. Forty-three patients with ileal carcinoids were investigated by high-resolution array-based comparative genomic hybridization. The average number of copy number alterations (CNAs) per tumour was 7.1 (range 1–22), with losses being more common than gains (ratio 1.4). The most frequent CNA was loss of chromosome 18 (74%). Other frequent CNAs were gain of chromosome 4, 5, 14 and 20, and loss of 11q22.1–q22.2, 11q22.3–q23.1 and 11q23.3, and loss of 16q12.2–q22.1 and 16q23.2-qter. Two distinct patterns of CNAs were found; the majority of tumours was characterized by loss of chromosome 18 while a subgroup of tumours had intact chromosome 18, but gain of chromosome 14. Survival analysis, using a series of Poisson regressions including recurrent CNAs, demonstrated that gain of chromosome 14 was a strong predictor of poor survival.